Evidence map›Paper›PMID 29682858›Full record

ArticleHuman brain mapping2018

Natural biological variation of white matter microstructure is accentuated in Huntington's disease.

Sarah Gregory, Helen Crawford, Kiran Seunarine, Blair Leavitt, Alexandra Durr, Raymund A C Roos, Rachael I Scahill, Sarah J Tabrizi, Geraint Rees, Douglas Langbehn and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Human brain mapping, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Diffusion imaging in Huntington's disease: comprehensive review.Journal of neurology, neurosurgery, and psychiatry · 2020
    Review
  11. A Critical Review of White Matter Changes in Huntington's Disease.Movement disorders : official journal of the Movement Disorder Society · 2020
    Review
  12. Article
  13. Article
  14. Characterizing White Matter in Huntington's Disease.Movement disorders clinical practice · 2020
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 6 countries.

Sarah GregoryHuntington's Disease Research Centre, UCL Institute of Neurology, London, United Kingdom.ORCID 0000-0003-4620-6963
Helen CrawfordHuntington's Disease Research Centre, UCL Institute of Neurology, London, United Kingdom.
Kiran SeunarineDevelopmental Imaging and Biophysics Section, UCL Institute of Child Health, London, WC1N 1EH, United Kingdom.
Blair LeavittCentre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, BC, V5Z 4H4, Canada.
Alexandra DurrAPHP Department of Genetics, Groupe Hospitalier Pitié-Salpêtrière, and Institut du Cerveau et de la Moelle, INSERM U1127, CNRS UMR7225, Sorbonne Universités - UPMC Université Paris VI UMR_S1127, Paris, France.
Raymund A C RoosDepartment of Neurology, Leiden University Medical Centre, Leiden, 2300RC, The Netherlands.
Rachael I ScahillHuntington's Disease Research Centre, UCL Institute of Neurology, London, United Kingdom.ORCID 0000-0002-1832-106X
Sarah J TabriziHuntington's Disease Research Centre, UCL Institute of Neurology, London, United Kingdom.
Geraint ReesWellcome Trust Centre for Neuroimaging, University College London, London, United Kingdom.
Douglas LangbehnDepartments of Psychiatry and Biostatistics, University of Iowa, Iowa City, Iowa.
Michael OrthDepartment of Neurology, Ulm University Hospital, Ulm, Germany.ORCID 0000-0002-6913-3536
Huntington's Disease Association · GBCentre National de la Recherche Scientifique · FRLeiden University · NLUniversity College London · GBUniversity Hospital Ulm · DEUniversity of British Columbia · CAUniversity of Iowa · USWellcome Centre for Human Neuroimaging · GB

Funding

Department of Health's NIHR Biomedical Research CentreWellcome TrustWellcome Trust Collaborative Award 200181/Z/15/Z
6 · The paper itself

Abstract

Huntington's disease (HD) is a monogenic neurodegenerative disorder caused by a CAG-repeat expansion in the Huntingtin gene. Presence of this expansion signifies certainty of disease onset, but only partly explains age at which onset occurs. Genome-wide association studies have shown that naturally occurring genetic variability influences HD pathogenesis and disease onset. Investigating the influence of biological traits in the normal population, such as variability in white matter properties, on HD pathogenesis could provide a complementary approach to understanding disease modification. We have previously shown that while white matter diffusivity patterns in the left sensorimotor network were similar in controls and HD gene-carriers, they were more extreme in the HD group. We hypothesized that the influence of natural variation in diffusivity on effects of HD pathogenesis on white matter is not limited to the sensorimotor network but extends to cognitive, limbic, and visual networks. Using tractography, we investigated 32 bilateral pathways within HD-related networks, including motor, cognitive, and limbic, and examined diffusivity metrics using principal components analysis. We identified three independent patterns of diffusivity common to controls and HD gene-carriers that predicted HD status. The first pattern involved almost all tracts, the second was limited to sensorimotor tracts, and the third encompassed cognitive network tracts. Each diffusivity pattern was associated with network specific performance. The consistency in diffusivity patterns across both groups coupled with their association with disease status and task performance indicates that naturally-occurring patterns of diffusivity can become accentuated in the presence of the HD gene mutation to influence clinical brain function.

Indexed as

Biological Variation, IndividualBrain MappingDiffusion Tensor ImagingAdultFemaleGenotypeHumansHuntingtin ProteinHuntington DiseaseMaleMiddle AgedNerve NetNeuropsychological TestsPsychomotor PerformanceWhite MatterHTT protein, humanHuntingtin ProteinDiffusion Tensor ImagingHuntington's diseasenatural variability

Identifiers

PMID29682858
PMCPMC6099203
OpenAlexW2799820439

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.